GRANULES INDIA
Back to Balance Sheet
|
GRANULES INDIA Last 5 Year Total Non-Current Liabilities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Total Non-Current Liabilities | ₹466 Cr | ₹176 Cr | ₹255 Cr | ₹283 Cr | ₹366 Cr |
What is the latest Total Non-Current Liabilities ratio of GRANULES INDIA ?
| Year | Total Non-Current Liabilities |
|---|---|
| Mar2025 | ₹466 Cr |
| Mar2024 | ₹176 Cr |
| Mar2023 | ₹255 Cr |
| Mar2022 | ₹283 Cr |
| Mar2021 | ₹366 Cr |
How is Total Non-Current Liabilities of GRANULES INDIA Trending?
| Years | Total Non-Current Liabilities | % Change | |
|---|---|---|---|
| Mar2025 | ₹466 Cr | 164.71 | |
| Mar2024 | ₹176 Cr | -30.89 | |
| Mar2023 | ₹255 Cr | -9.94 | |
| Mar2022 | ₹283 Cr | -22.79 | |
| Mar2021 | ₹366 Cr | - | |
Compare Total Non-Current Liabilities of peers of GRANULES INDIA
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| GRANULES INDIA | ₹13,466.2 Cr | -1.9% | -0.3% | -3.2% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹406,147.0 Cr | 0.2% | 2.3% | -9.3% | Stock Analytics | |
| DIVIS LABORATORIES | ₹176,708.0 Cr | -1.3% | 9.1% | 16.7% | Stock Analytics | |
| CIPLA | ₹121,525.0 Cr | 0.2% | -0.6% | -3.8% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹121,147.0 Cr | 0.6% | 1% | 10.8% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹100,596.0 Cr | 0.6% | -3.5% | -4.3% | Stock Analytics | |
GRANULES INDIA Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| GRANULES INDIA | -1.9% |
-0.3% |
-3.2% |
| SENSEX | -1.4% |
1.7% |
4.8% |
You may also like the below Video Courses